Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 48.65 Delayed Data As of Dec 08 |  -0.82 / -1.66%Today’s Change | 32.69 Today|||52-Week Range 51.89 | +28.81% Year-to-Date |
Institutional investors purchased a net $7.4 million shares of IONS during the quarter ended June 2019, and now own 97.86% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 59.41% |
| Other institutional | 38.45% |
| Individual stakeholders | 1.12% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/30/2023 | PICTET ASSET MANAGEMENT SA Bought 3.2 Million shares of Ionis Pharmaceuticals Inc |
| 9/30/2023 | MACQUARIE INVESTMENT MANAGEMENT ... Bought 1.4 Million shares of Ionis Pharmaceuticals Inc |
| 9/30/2023 | BVF PARTNERS LP Bought 1.2 Million shares of Ionis Pharmaceuticals Inc |
Top 10 Owners of Ionis Pharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Management & Research Co... | 15.00% | 21,498,922 | 951,757,277 | +35,106 | +0.16% |
| The Vanguard Group, Inc. | 9.97% | 14,295,257 | 632,851,027 | -19,996 | -0.14% |
| T. Rowe Price Investment Manageme... | 9.16% | 13,123,055 | 580,957,645 | +39,328 | +0.30% |
| Bellevue Asset Management AG | 6.44% | 9,233,700 | 408,775,899 | -146,600 | -1.56% |
| BlackRock Fund Advisors | 5.01% | 7,180,266 | 317,870,376 | +50,087 | +0.70% |
| ClearBridge Investments LLC | 3.38% | 4,840,695 | 214,297,568 | -346,509 | -6.68% |
| BVF Partners LP | 2.79% | 4,004,613 | 177,284,218 | +1,158,598 | +40.71% |
| SSgA Funds Management, Inc. | 2.76% | 3,955,029 | 175,089,134 | -19,424 | -0.49% |
| T. Rowe Price Associates, Inc. (I... | 2.52% | 3,614,022 | 159,992,754 | -78,407 | -2.12% |
| Tweedy, Browne Co. LLC | 2.45% | 3,510,173 | 155,395,359 | -30,685 | -0.87% |
Top 10 Mutual Funds Holding Ionis Pharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BB Biotech AG | 6.35% | 9,100,000 | 402,857,000 | -199,700 | -2.15% |
| Fidelity Growth Company Fund | 4.78% | 6,849,494 | 303,227,099 | 0 | 0.00% |
| T Rowe Price Mid Cap Growth Fund | 3.30% | 4,725,400 | 209,193,458 | -20,800 | -0.44% |
| Vanguard Total Stock Market ETF | 2.98% | 4,265,563 | 188,836,474 | +8,442 | +0.20% |
| Vanguard Small Cap Index Fund | 2.45% | 3,512,056 | 155,478,719 | +7,004 | +0.20% |
| Fidelity Growth Company K6 Fund | 1.82% | 2,603,975 | 115,277,973 | 0 | 0.00% |
| Tweedy Browne International Value... | 1.81% | 2,589,316 | 114,629,019 | 0 | 0.00% |
| Fidelity Series Growth Company Fu... | 1.43% | 2,048,969 | 90,707,858 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 1.42% | 2,036,178 | 90,141,600 | +39,471 | +1.98% |
| Vanguard Small Cap Growth Index F... | 1.37% | 1,963,027 | 86,903,205 | +4,218 | +0.22% |